Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

248
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVARTIS AG
04/08 Patent Issued for Correction of Check Processing Defects
04/08 NOVARTIS : $65,202 Federal Contract Awarded to Alcon Laboratories
04/07 NOVARTIS : With patent dispute settled, Penn and Novartis can push ahead with im..
04/07 NOVARTIS : New therapeutic option now available for select treatment resistant l..
04/06 JUNO THERAPEUTICS : Announces Patent Litigation Settlement
04/06DJBristol-Myers Invests in uniQure in Heart-Disease Pact -- 2nd Update
04/06DJJuno Therapeutics Settles Patent Dispute With Novartis
04/06 NOVARTIS : Juno Therapeutics Announces Patent Litigation Settlement
04/05 NOVARTIS : FDA Approves Jadenu for Treatment for Patients With Chronic Iron Over..
04/03DJBayer's CEO Injects a Dose of U.S. Risk-Taking
04/03DJAt Bayer, A Dose Of US Risk-Taking
04/03 NOVARTIS : Alcon Research Assigned Patent
04/02 NOVARTIS : GSK to establish global vaccines R&D centre in the US | GSK
04/02 NOVARTIS : GSK statement on meningitis vaccination in the UK | GSK
04/02 NOVARTIS : Cheaper eye drugs claim
04/02 NOVARTIS : Cheaper eye drugs claim
04/02 NOVARTIS : GSK to establish global vaccines R%7ED centre in the US
04/01 Otonomy Appoints Dean Hakanson, M.D., as Chief Medical Officer
04/01 NOVARTIS : Nexvet Biopharma Appoints Dr. George Gunn as Chairman
04/01 NOVARTIS : New Novartis data show more Cosentyx™-treated psoriasis patient..
04/01 NOVARTIS : Patent Issued for Solid Dosage Form Containing a Taste Masked Active ..
04/01 NOVARTIS : Patent Issued for Preparation of Anhydrous and Hydrated Polymorphs 4-..
04/01 NOVARTIS : Researchers Submit Patent Application, "Oct Probe with Pivoting Fiber..
04/01 NOVARTIS : presents Cosentyx™ two-year efficacy and safety data showing su..
04/01 NOVARTIS : Patent Application Titled "Oct Probe with Bowing Flexor" Published On..
04/01 Otonomy Appoints Dean Hakanson, M.D., as Chief Medical Officer
03/30 NOVARTIS : announces FDA approval for JadenuTM to simplify treatment administrat..
03/30 NOVARTIS : announces FDA approval for JadenuTM to simplify treatment administrat..
03/30DJADR Shares End Higher; Carnival Shares Rise
03/30 Novartis digs deeper into cancer with up to $750 million Aduro deal
03/30 Glaxo Reaches Agreement With UK Government For Meningitis B Vaccine
03/30 NOVARTIS : GSK statement on meningitis vaccination in the UK | GSK
03/30 NOVARTIS : accelerates cancer immunotherapy efforts with Aduro Biotech alliance ..
03/30 NOVARTIS : accelerates cancer immunotherapy efforts with Aduro Biotech alliance ..
03/27 NOVARTIS : Alcon Research Assigned Patent
03/27 Ablynx announces extension of ion channel research collaboration with merck &..
03/26 NOVARTIS : BUSINESS INSIDE CHRONICLE BATH Family's greatest hope yet in the figh..
03/26 BIOLINERX : Posts Year End 2014 Financial Results
03/26 INCYTE : Jakavi (ruxolitinib) Gets European Commission Approval as First Targete..
03/25 NOVARTIS : Patent Issued for Combination Therapy
03/25 NOVARTIS : presented results of two new studies at AAD: CLEAR study showed Cosen..
03/25 NOVARTIS : Semma Therapeutics Enters into Agreement with Novartis
03/23 GENVEC : Reports Fourth Quarter And 2014 Year-End Financial Results
03/23 HANMIPHARM : Hanmi Pharma Enters into Co-Marketing Agreement with Novartis Korea
03/22 Bristol, Sanofi and Novartis drugs to shine among 2015 launches
03/22 BIOLINERX : Reports Year End 2014 Financial Results
03/22 Currency hedging takes on new importance for global stock funds
03/22 Currency hedging takes on new importance for global stock funds
03/21 Report slams anti-TB drug makers
03/21 NOVARTIS : Atlantic Information Services Webinar to Discuss Payer Strategies for..
03/21 NOVARTIS' : Cosentyx(TM) two-year data shows sustained effect and favorable safe..
03/21 NOVARTIS' : Cosentyx(TM) two-year data shows sustained effect and favorable safe..
03/21 NOVARTIS : ' Cosentyx(TM) two-year data shows sustained effect and favorable saf..
03/20 VALNEVA : Reports Annual Results 2014: the company announces a significant impro..
03/20 NOVARTIS : New Novartis data shows Cosentyx(TM) is significantly superior to Ste..
03/20 NOVARTIS : New Novartis data shows Cosentyx(TM) is significantly superior to Ste..
03/20 NOVARTIS : Lions Health Brings Google, WebMD, Walgreens, Novartis, Weber Shandwi..
03/20 INCYTE : Jakavi (ruxolitinib) Receives European Commission Approval as First Tar..
03/19DJNOVARTIS : Judge Denies Amgen's Request to Block Novartis's Biosimilar of Neupog..
03/18 OPHTHOTECH : Achieves Second $50 Million Enrollment Milestone under Ex-US Licens..
03/18 NOVARTIS : Patent Issued for Method of Controlling a Surgical System Based on a ..
03/18 ANACOR PHARMACEUTICALS : Reports 2014 Fourth Quarter and Year-End Financial Resu..
03/18 NOVARTIS : Ex-workers sue Alcon, allege gender and pay bias
03/18 NOVARTIS : receives EU approval for Jakavi in polycythemia vera, first targeted ..
03/17 NOVARTIS : Former Alcon employees sue company for gender and pay discrimination
03/17DJADR Shares End Mixed; BHP Billiton Shares Rise
03/17 Novartis unit hit with $110 million gender discrimination suit
03/17DJNovartis Gets EU Approval for Jakavi Rare Blood Cancer Drug
03/17 NOVARTIS : receives EU approval for Jakavi® in polycythemia vera, first targeted..
03/17 NOVARTIS : receives EU approval for Jakavi® in polycythemia vera, first targeted..
03/16 NOVARTIS : Special Notice - 65-- The Southern Region Contracting Office, Fort Ho..
03/16 NOVARTIS : to present new late-breaking CosentyxTM data at AAD 2015 showing sign..
03/15 NOVARTIS : Sandoz to Pay $12.64 Million in CMP Settlement with HHS OIG for Misre..
03/13DJOxford Biomedica Hails Novartis Contract, Narrows Loss
03/13 NOVARTIS : to present new late-breaking CosentyxTM data at AAD 2015 showing sign..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF